FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.9.1  |  FHIR Version n/a  User: [n/a]

2700811000001107: Cyproterone 50mg tablets (Kent Pharma (UK) Ltd) 56 tablet 2 x 28 tablets (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1882141000001117 Cyproterone 50mg tablets (Kent Pharma (UK) Ltd) 56 tablet en Synonym Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module
1882151000001119 Cyproterone 50mg tablets (Kent Pharma (UK) Ltd) 56 tablet (product) en Fully specified name Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module
2372891000001113 Cyproterone 50mg tablets (Kent Pharma (UK) Ltd) 56 tablet 2 x 28 tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
2372901000001114 Cyproterone 50mg tablets (Kent Pharma (UK) Ltd) 56 tablet 2 x 28 tablets (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
25865701000001111 Cyproterone 50mg tablets (Kent Pharmaceuticals Ltd) 56 tablet (product) en Fully specified name Inactive Only initial character case insensitive SNOMED CT United Kingdom drug extension module
25865801000001119 Cyproterone 50mg tablets (Kent Pharmaceuticals Ltd) 56 tablet en Synonym Inactive Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Cyproterone 50mg tablets (Kent Pharma (UK) Ltd) 56 tablet 2 x 28 tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Cyproterone 50mg tablets (Kent Pharma (UK) Ltd) 56 tablet 2 x 28 tablets Is a Cyproterone 50mg tablets 56 tablet true Inferred relationship Existential restriction modifier
Cyproterone 50mg tablets (Kent Pharma (UK) Ltd) 56 tablet 2 x 28 tablets Is pack of Cyproterone 50mg tablets (Kent Pharma (UK) Ltd) false Inferred relationship Existential restriction modifier
Cyproterone 50mg tablets (Kent Pharma (UK) Ltd) 56 tablet 2 x 28 tablets Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Cyproterone 50mg tablets (Kent Pharma (UK) Ltd) 56 tablet 2 x 28 tablets Has active ingredient Cyproterone acetate false Inferred relationship Existential restriction modifier
Cyproterone 50mg tablets (Kent Pharma (UK) Ltd) 56 tablet 2 x 28 tablets Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Cyproterone 50mg tablets (Kent Pharma (UK) Ltd) 56 tablet 2 x 28 tablets Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Cyproterone 50mg tablets (Kent Pharma (UK) Ltd) 56 tablet 2 x 28 tablets Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Cyproterone 50mg tablets (Kent Pharma (UK) Ltd) 56 tablet 2 x 28 tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Cyproterone 50mg tablets (Kent Pharma (UK) Ltd) 56 tablet 2 x 28 tablets VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Cyproterone 50mg tablets (Kent Pharma (UK) Ltd) 56 tablet 2 x 28 tablets Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Cyproterone 50mg tablets (Kent Pharma (UK) Ltd) 56 tablet 2 x 28 tablets Has AMP Cyproterone 50mg tablets (Kent Pharma (UK) Ltd) true Inferred relationship Existential restriction modifier
Cyproterone 50mg tablets (Kent Pharma (UK) Ltd) 56 tablet 2 x 28 tablets Has specific active ingredient Cyproterone acetate true Inferred relationship Existential restriction modifier
Cyproterone 50mg tablets (Kent Pharma (UK) Ltd) 56 tablet 2 x 28 tablets Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Cyproterone 50mg tablets (Kent Pharma (UK) Ltd) 56 tablet 2 x 28 tablets Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start